KVUE - Kenvue Inc. So'nggi Yangiliklar | Finranks

Videolar

03.11.2025

Positive

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

03.11.2025

Positive

Kimberly-Clark Buying Tylenol Maker Kenvue in $40 Billion Deal

03.11.2025

Positive

Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant

03.11.2025

Positive

Another Big Earnings Week Ahead, KVUE Soars on KMB $48.7B Deal

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
KVUE	Canaccord Genuity	Hold	undefined >> $15	October 29th 2025
KVUE	Rothschild & Co Redburn	Buy	undefined >> $22	September 26th 2025
KVUE	Redburn Atlantic	Neutral	undefined >> $24	April 10th 2025

Press-relizlar

17.02.2026

Kenvue Reports Fourth Quarter and Full Year 2025 Results

SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the fiscal fourth quarter and full year ended December 28, 2025. “We ended 2025 with stronger top- and bottom-line performance in the fourth quarter, which reflected both disciplined execution against our strategic priorities, as well as a more favorable year-ago comparison on sales,” said Kirk Perry, Chief Executive Officer. “As we look to 2026, we remain focused on continuing to enhance our performan.